A carregar...
Comparison of Pegfilgrastim Prescribing Practice to National Guidelines at a University Hospital Outpatient Oncology Clinic
PURPOSE: Pegfilgrastim reduces the risk of febrile neutropenia (FN) and is indicated as primary prophylaxis when the risk of FN approaches 20% in each chemotherapy cycle. There have been few reports evaluating the appropriate use of pegfilgrastim in comparison with published guidelines. We sought to...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Clinical Oncology
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3710170/ https://ncbi.nlm.nih.gov/pubmed/23942922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2012.000662 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|